Changes in Early-Stage Lung Cancer Treatments Options

In this podcast, Drs. Linda Martin (UVA) and Dennis Wigle (Mayo Clinic Rochester, MN) discuss key updates in the treatment of early stage surgically resectable non small cell lung cancer from the 2025 American Society of Clinical Oncology Annual Meeting. Topics include updated survival data from the CheckMate 816 trial of neoadjuvant nivolumab plus chemotherapy, the practice impact of PROSPECT lung accrual, and results from the NeoADAURA trial of neoadjuvant osimertinib. This episode was sponsored by BMS.